Rosacea Review - Newsletter of the National Rosacea SocietyRosacea Review - Newsletter of the National Rosacea Society

medical therapy

Her Doctor Helps Choose Best Skin-Care Products

Theresa Pignotti jokes that she was born in a dermatologist's office and saw her dermatologist more often than her own father while growing up. Although she had impetigo as a newborn and acne as an adolescent, she was still taken aback by her first rosacea flare-up. In fact, the 54-year-old respiratory therapist from Rhode Island vividly recalls that very day in 2000.

"I thought I would treat myself to a facial for my birthday," Theresa said, "but it just made my face go crazy. I looked like I was sunburned, and I had pimples and pustules all over."

Patient Overcomes Five-Year Break in Medical Therapy

Andrea considered herself somewhat fortunate when she was diagnosed with rosacea about 15 years ago because her doctor worked closely with her to find just the right combination of medications and skin care products for her sensitive skin. The 46-year-old Russian translator from Maryland often stood in front of large crowds when she performed simultaneous interpretations, and she was grateful that she was able to keep her condition under control with oral and topical therapy.

Survey Shows Rosacea's Emotional Toll, Positive Effects of Medical Therapy

Rosacea often casts a negative spell on quality of life and emotional well-being that is in direct proportion to its physical effects, according to a new survey by the National Rosacea Society. Fortunately, most rosacea patients reported they are able to overcome these drawbacks through effective medical therapy and coping techniques.

Q&A: Long-Term Medication & Craving Triggers

Q. If I take long-term medication consistently, will it lose its effectiveness?

A. Topical therapy is commonly prescribed to control rosacea on a long-term basis, and no evidence has suggested that it loses effectiveness. A long-term controlled clinical study found that 77 percent of rosacea patients consistently using topical metronidazole remained in remission, while 42 percent of patients using no therapy had relapsed within six months.

Subscribe to medical therapy